BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38848215)

  • 21. METTL7B promotes migration and invasion in thyroid cancer through epithelial-mesenchymal transition.
    Ye D; Jiang Y; Sun Y; Li Y; Cai Y; Wang Q; Wang O; Chen E; Zhang X
    J Mol Endocrinol; 2019 Jul; 63(1):51-61. PubMed ID: 31121562
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Primary glioblastomas express mesenchymal stem-like properties.
    Tso CL; Shintaku P; Chen J; Liu Q; Liu J; Chen Z; Yoshimoto K; Mischel PS; Cloughesy TF; Liau LM; Nelson SF
    Mol Cancer Res; 2006 Sep; 4(9):607-19. PubMed ID: 16966431
    [TBL] [Abstract][Full Text] [Related]  

  • 23. circ-PSD3 promoted proliferation and invasion of papillary thyroid cancer cells via regulating the miR-7-5p/METTL7B axis.
    Zhu J; Wang Y; Yang C; Feng Z; Huang Y; Liu P; Chen F; Deng Z
    J Recept Signal Transduct Res; 2022 Jun; 42(3):251-260. PubMed ID: 33858297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Heart failure-related genes associated with oxidative stress and the immune landscape in lung cancer.
    Duan R; Ye K; Li Y; Sun Y; Zhu J; Ren J
    Front Immunol; 2023; 14():1167446. PubMed ID: 37275875
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated FOXG1 and SOX2 in glioblastoma enforces neural stem cell identity through transcriptional control of cell cycle and epigenetic regulators.
    Bulstrode H; Johnstone E; Marques-Torrejon MA; Ferguson KM; Bressan RB; Blin C; Grant V; Gogolok S; Gangoso E; Gagrica S; Ender C; Fotaki V; Sproul D; Bertone P; Pollard SM
    Genes Dev; 2017 Apr; 31(8):757-773. PubMed ID: 28465359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Downregulation of hsa-miR-30b-3p Inhibits the Oncogenicity of Lung Adenocarcinoma by Targeting the
    Li N; Li R; Song B; Ge H; Qu Y
    J Oncol; 2022; 2022():6883140. PubMed ID: 35646115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modeling Patient-Derived Glioblastoma with Cerebral Organoids.
    Linkous A; Balamatsias D; Snuderl M; Edwards L; Miyaguchi K; Milner T; Reich B; Cohen-Gould L; Storaska A; Nakayama Y; Schenkein E; Singhania R; Cirigliano S; Magdeldin T; Lin Y; Nanjangud G; Chadalavada K; Pisapia D; Liston C; Fine HA
    Cell Rep; 2019 Mar; 26(12):3203-3211.e5. PubMed ID: 30893594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Robust Pipeline for the Multi-Stage Accelerated Differentiation of Functional 3D Cortical Organoids from Human Pluripotent Stem Cells.
    Whye D; Wood D; Saber WA; Norabuena EM; Makhortova NR; Sahin M; Buttermore ED
    Curr Protoc; 2023 Jan; 3(1):e641. PubMed ID: 36633423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dynamics of activating and repressive histone modifications in
    Abdusselamoglu MD; Landskron L; Bowman SK; Eroglu E; Burkard T; Kingston RE; Knoblich JA
    Development; 2019 Dec; 146(23):. PubMed ID: 31748204
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative expression study of the endo-G protein coupled receptor (GPCR) repertoire in human glioblastoma cancer stem-like cells, U87-MG cells and non malignant cells of neural origin unveils new potential therapeutic targets.
    Fève M; Saliou JM; Zeniou M; Lennon S; Carapito C; Dong J; Van Dorsselaer A; Junier MP; Chneiweiss H; Cianférani S; Haiech J; Kilhoffer MC
    PLoS One; 2014; 9(3):e91519. PubMed ID: 24662753
    [TBL] [Abstract][Full Text] [Related]  

  • 31. N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer.
    Berger A; Brady NJ; Bareja R; Robinson B; Conteduca V; Augello MA; Puca L; Ahmed A; Dardenne E; Lu X; Hwang I; Bagadion AM; Sboner A; Elemento O; Paik J; Yu J; Barbieri CE; Dephoure N; Beltran H; Rickman DS
    J Clin Invest; 2019 Jul; 129(9):3924-3940. PubMed ID: 31260412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in chromatin state reveal ARNT2 at a node of a tumorigenic transcription factor signature driving glioblastoma cell aggressiveness.
    Bogeas A; Morvan-Dubois G; El-Habr EA; Lejeune FX; Defrance M; Narayanan A; Kuranda K; Burel-Vandenbos F; Sayd S; Delaunay V; Dubois LG; Parrinello H; Rialle S; Fabrega S; Idbaih A; Haiech J; Bièche I; Virolle T; Goodhardt M; Chneiweiss H; Junier MP
    Acta Neuropathol; 2018 Feb; 135(2):267-283. PubMed ID: 29149419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An update on the epigenetics of glioblastomas.
    Ferreira WA; Pinheiro Ddo R; Costa Junior CA; Rodrigues-Antunes S; Araújo MD; Leão Barros MB; Teixeira AC; Faro TA; Burbano RR; Oliveira EH; Harada ML; Borges Bdo N
    Epigenomics; 2016 Sep; 8(9):1289-305. PubMed ID: 27585647
    [TBL] [Abstract][Full Text] [Related]  

  • 34. VGLL4 promotes vascular endothelium specification via TEAD1 in the vascular organoids and human pluripotent stem cells-derived endothelium model.
    Quan Y; Hu M; Jiang J; Jin P; Fan J; Li M; Fan X; Gong Y; Yang Y; Wang Y
    Cell Mol Life Sci; 2023 Jul; 80(8):215. PubMed ID: 37468661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Growth factor independence underpins a paroxysmal, aggressive Wnt5a
    Trivieri N; Visioli A; Mencarelli G; Cariglia MG; Marongiu L; Pracella R; Giani F; Soriano AA; Barile C; Cajola L; Copetti M; Palumbo O; Legnani F; DiMeco F; Gorgoglione L; Vescovi AL; Binda E
    J Exp Clin Cancer Res; 2022 Apr; 41(1):139. PubMed ID: 35414102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance.
    Liau BB; Sievers C; Donohue LK; Gillespie SM; Flavahan WA; Miller TE; Venteicher AS; Hebert CH; Carey CD; Rodig SJ; Shareef SJ; Najm FJ; van Galen P; Wakimoto H; Cahill DP; Rich JN; Aster JC; Suvà ML; Patel AP; Bernstein BE
    Cell Stem Cell; 2017 Feb; 20(2):233-246.e7. PubMed ID: 27989769
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cells isolated from residual intracranial tumors after treatment express iPSC genes and possess neural lineage differentiation plasticity.
    Palanichamy K; Jacob JR; Litzenberg KT; Ray-Chaudhury A; Chakravarti A
    EBioMedicine; 2018 Oct; 36():281-292. PubMed ID: 30269995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Computational identification of specific genes for glioblastoma stem-like cells identity.
    Fiscon G; Conte F; Licursi V; Nasi S; Paci P
    Sci Rep; 2018 May; 8(1):7769. PubMed ID: 29773872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Krüppel-like factor 9 and histone deacetylase inhibitors synergistically induce cell death in glioblastoma stem-like cells.
    Tung B; Ma D; Wang S; Oyinlade O; Laterra J; Ying M; Lv SQ; Wei S; Xia S
    BMC Cancer; 2018 Oct; 18(1):1025. PubMed ID: 30348136
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mesenchymal differentiation of glioblastoma stem cells.
    Ricci-Vitiani L; Pallini R; Larocca LM; Lombardi DG; Signore M; Pierconti F; Petrucci G; Montano N; Maira G; De Maria R
    Cell Death Differ; 2008 Sep; 15(9):1491-8. PubMed ID: 18497759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.